Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Cystic Fibrosis Market 2015-2022 - Global Strategic Business Report 2017 - FDA Approves Vertex's ORKAMBI - Research and Markets

Research and Markets
Posted on: 20 Mar 17

Research and Markets has announced the addition of the "Cystic Fibrosis - Global Strategic Business Report" report to their offering.

This report analyzes the worldwide markets for Cystic Fibrosis in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2022. Market data and analytics are derived from primary and secondary research.

The report profiles 56 companies, including many key and niche players such as:

  • Advanced Inhalation Therapies (AIT) Ltd. (Israel)
  • Alaxia SAS (France)
  • AlgiPharma AS (Norway)
  • Anthera Pharmaceuticals Inc. (USA)
  • Arch BioPartners (Canada)
  • Celtaxsys Inc. (USA)
  • Concert Pharmaceuticals Inc. (USA)
  • Corbus Pharmaceuticals Holdings Inc.(USA)
  • CURx Pharmaceuticals (USA)
  • Nivalis Therapeutics Inc. (USA)
  • NovaBiotics Ltd. (UK)
  • Parion Sciences Inc. (USA)
  • Pharmaxis Ltd (Australia)
  • PTC Therapeutics Inc. (USA)
  • Pulmatrix Inc. (USA)
  • AbbVie Inc. (USA)
  • Galapagos NV (Belgium)
  • Genentech Inc. (USA)
  • Gilead Sciences Inc. (USA)
  • Novartis AG (Switzerland)
  • Vertex Pharmaceuticals (USA)

Key Topics Covered:

1. Market Overview

2. Research In Cystic Fibrosis Space

3. Disease Overview

4. Cystic Fibrosis Treatment: An Overview

5. Clinical Studies

6. Product Launches/Approvals

7. Recent Industry Activity

8. Select Clinical-Stage Players

9. Focus On Select Global Players

10. Global Market Perspective

Total Companies Profiled: 56 (including Divisions/Subsidiaries 58)

- The United States (30)

- Canada (4)

- Europe (20)

- France (2)

- Germany (2)

- The United Kingdom (3)

- Italy (2)

- Rest of Europe (11)

- Asia-Pacific (Excluding Japan) (1)

- Middle East (3)

For more information about this report visit

View source version on

Business Wire

Last updated on: 20/03/2017

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.